Clinical trial

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

NCT00425919

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-01-01

PhasePHASE2

Study timeline

Study start (unknown)2007-01-01Date precision: month

Registry last updated2007-12-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

PPM-204DRUG

Sponsors & collaborators

Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor

Mapped research locations

MoscowRussia4 BeijingChina2 Saint PetersburgRussia2 BucharestRomania2 Mexico CityMexico2 New YorkNew York, United States1 Los AngelesCalifornia, United States1 TorontoOntario, Canada1 AustinTexas, United States1 OmahaNebraska, United States1 RichmondVirginia, United States1 EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00425919 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.